Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/1990
11/27/1990CA1276899C Method for purifying a gene-expression product produced by recombinant dna technique
11/27/1990CA1276897C Hypocholesterolemically active rna fractions
11/27/1990CA1276884C2 Protein antibody derived from serum of a bovid
11/27/1990CA1276883C2 Protein antibody composition derived from bovid milk and from avian egg
11/27/1990CA1276882C Method for controlling bleeding
11/26/1990WO1990014359A1 Biologically active polypeptides based on transforming growth factor-beta sequences
11/26/1990CA2057057A1 Interleukin-2 in treating birds
11/26/1990CA2017552A1 Amino-substituted heterocycles as renin inhibitors
11/26/1990CA2017541A1 Polyethylene glycol derivatives, modified peptides and production thereof
11/25/1990WO1990014433A1 Monoclonal antibodies which recognise malignant cells from bladder carcinomas
11/25/1990WO1990014362A1 Atrial peptide derivatives
11/25/1990CA2033198A1 Atrial peptide derivatives
11/22/1990EP0398817A1 Interleukin 1 inhibitor
11/22/1990EP0398753A2 Metalloproteinase inhibitor
11/22/1990EP0398707A1 Treatment and diagnosis of human lymphotropic viruses
11/22/1990EP0398619A2 Stabilized compositions containing epidermal growth factor
11/22/1990EP0398558A1 Isolation and structual elucidation of the cytostatic linear depsipeptide dolastatin 15
11/22/1990EP0398451A1 Vasorelaxant substance obtainable from human atrium
11/22/1990EP0398362A1 Human prourokinase variants, methods of producing same, DNA sequences, plasmids and hosts therefor
11/22/1990EP0398361A2 Human prourokinase variants, methods of producing same, DNA sequences, plasmids and hosts therefor
11/22/1990EP0398327A1 Tumor necrosis factor binding protein II, its purification and antibodies thereto
11/22/1990EP0398322A1 Synthetic peptides capable of stimulating a T-cellular immunity
11/22/1990EP0398305A2 Anthracycline conjugates having a novel linker and methods for their production
11/22/1990EP0398288A2 Process for preparing optically active 2-arylalkanoic acids, in particular 2-arylpropionic acids
11/22/1990EP0398287A1 Pharmaceutical preparation
11/22/1990EP0398143A1 Labeled chemotactic peptides to image focal sites of infection or inflammation
11/22/1990EP0398024A1 Conjugates for tumor localization and/or tumortherapy
11/22/1990EP0397985A1 Polypeptide (calcitonin) derivatives
11/22/1990EP0397834A1 Method for identifying active domains and amino acid residues in polypeptides and hormone variants
11/22/1990EP0397821A1 A novel family of high affinity, modified antibodies for cancer treatment
11/22/1990EP0397779A1 Renin inhibiting peptides with polar end groups
11/22/1990EP0397764A1 Method of reducing immunoglobulin e responses
11/22/1990EP0397751A1 Grf analogs
11/22/1990CA2017279A1 Process to prepare metastasis-inhibitory factor
11/22/1990CA2017237A1 Human mammary cell growth inhibitor and methods of production and use
11/21/1990CN1047085A Renin-inhibiting dipeptides, process for their preparation, agents containing them and their use
11/21/1990CN1047084A Dipeptide derivatives having enzyme-inhibitory action
11/21/1990CN1047078A Polyamines and polypetides useful as anta-gonists of excitatory amino acid neuro-transmitters and/or as blockers of calcium channels
11/20/1990US4971993 Dipeptide derivatives and antihypertensive drugs containing them
11/20/1990US4971953 Anticoagulant peptide alcohols
11/20/1990US4971952 Polypeptides, cardiovascular disorders
11/20/1990US4971951 Insulin potentiation therapy
11/20/1990US4971795 Enhancement of the cellular immune response using carbohydrate primed DTH effector cells expressing the CD5+/CD8- phenotype
11/20/1990US4971794 Production of antibodies using a mixture of strains of E. coli collectively expressing type I pili, CFA I pili, CFA II pili and K88 pili
11/20/1990US4971792 Antitumor agents, anticarcinogenic agents, administering
11/20/1990CA1276574C Monoclonal antibodies to activated platelets
11/20/1990CA1276559C2 Aminoacid derivatives composition in association with diuretic agents
11/19/1990CA2017180A1 Synthetic peptides capable of stimulating a t-cellular immunity
11/18/1990WO1990014360A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof
11/18/1990CA2458875A1 Tumor necrosis factor (tnf) binding protein ii, its purification and antibodies thereto
11/18/1990CA2056981A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof
11/18/1990CA2017178A1 Human prourokinase variants, methods of producing same, dna sequences, plasmids and hosts therefor
11/18/1990CA2017177A1 Human prourokinase variants, methods of producing same, dna sequences, plasmids and hosts therefor
11/18/1990CA2016261A1 Epoxysuccinic acid derivatives
11/18/1990CA2013766A1 Isolation and structural elucidation of the cytostatic linear depsipeptides dolastatin 13 and dehydrodolastatin 13
11/17/1990CA2016962A1 Polypeptide-antibody conjugate for inhibiting cell adhesion
11/16/1990WO1990014100A2 Somatotropin for increasing fertility in animals
11/16/1990CA2058422A1 Somatotropin for increasing fertility in animals
11/16/1990CA2016888A1 Pharmaceutical preparation
11/16/1990CA2016887A1 Process for preparing optically active 2-aryl-alkanoic acids, in particular 2-aryl propionic acids
11/16/1990CA2016842A1 Method for tapping the immunological repertoire
11/16/1990CA2016830A1 Methods for screening monoclonal antibodies for therapeutic use
11/15/1990WO1990013660A2 Human monoclonal antibodies to sero-specific determinants of gram-negative bacteria
11/15/1990WO1990013657A1 Microglobulin anti-b2 monoclonal antibodies
11/15/1990WO1990013653A1 Fusion proteins containing n-terminal fragments of human serum albumin
11/15/1990WO1990013652A1 Herpes simplex virus type 2-glycoprotein g proteins and polypeptides
11/15/1990WO1990013650A1 A plasmid dna construct including the gene encoding a mammalian beta-nerve growth factor
11/15/1990WO1990013649A1 Production of vascular endothelial cell growth factor and dna encoding same
11/15/1990WO1990013648A1 HIGH LEVEL EXPRESSION OF FUNCTIONAL HUMAN PLASMINOGEN ACTIVATOR INHIBITOR (PAI-1) IN $i(E. COLI)
11/15/1990WO1990013643A2 Glycoprotein hormone receptor molecules
11/15/1990WO1990013642A1 HUMAN LACTOFERRIN cDNA SEQUENCE
11/15/1990WO1990013640A1 Methods and materials for expression of human plasminogen in a eukaryotic cell system
11/15/1990WO1990013575A1 Novel tnf-inhibit proteins and their preparation
11/15/1990WO1990013574A1 A cytolytic t-cell activating factor derived from b-lymphocytes
11/15/1990WO1990013573A1 Polypeptides of feline t-cell lymphotropic lentivirus
11/15/1990WO1990013570A1 Human epidermal growth factor having substitution at position 11
11/15/1990WO1990013563A1 Synthetic pseudomonas aeruginosa pilin peptide and related vaccines and diagnostics
11/15/1990WO1990013562A1 Chemically modified cd4 peptide fragments having anti-retroviral properties
11/15/1990WO1990013317A1 Labeled chemotatic peptides to image focal sites of infection or inflammation
11/15/1990WO1990013315A1 Sex-associated membrane proteins and methods for increasing the probability that offspring will be of a desired sex
11/15/1990WO1990013312A1 Utilisation of adenyl cyclase or bacteria producing it used as vaccines against bordetella
11/15/1990WO1990013306A2 Small polypeptides
11/15/1990WO1990013300A1 ENDOTHELIAL CELL-LEUKOCYTE ADHESION MOLECULES (ELAMs) AND MOLECULES INVOLVED IN LEUKOCYTE ADHESION (MILAs)
11/15/1990WO1990013281A2 Method of suppressing hiv infection
11/15/1990WO1990013228A1 Oligopeptide mixture and composition containing the same
11/15/1990WO1990011292A3 Controlled-action anesthetic compounds and pharmaceutical compositions containing same
11/15/1990DE3941324A1 Aktivator fuer verletzte neurozyten zur verhuetung und behandlung von krankheiten Activator for injured neurocyte to prevent and treat disease
11/15/1990DE3915535A1 Compsns. for treating skin disorders - contain trigonellin or trigonellic acid
11/15/1990CA2425101A1 Tnf-inhibiting proteins and the preparation thereof
11/15/1990CA2016821A1 Culture of human tumor-infiltrating lymphocytes by combining gas permeable bags and a primary culture container
11/14/1990EP0397635A1 Peptide with anti-metastasis activity
11/14/1990EP0397633A2 Fibronectin binding protein as well as its preparation
11/14/1990EP0397571A1 Use of K-Caseinoglycopeptide for preparation of a composition, especially a drug, for prevention and treatment of thrombosis
11/14/1990EP0397556A1 N-Phenyl amides, methods for their preparation and medicaments containing them
11/14/1990EP0397447A1 Pharmaceutical compositions
11/14/1990EP0397427A1 Fluoro-amide derivatives having human leucocyte elastase inhibiting activity
11/14/1990EP0397420A1 Enzymatic removal of a protein amino-terminal sequence
11/14/1990EP0397419A2 Novel tumor-associated antigen, antibodies, compositions and uses therefor
11/14/1990EP0397409A1 The stabilization of organic compounds
11/14/1990EP0397227A1 Method of preparation of an antimicrobial particulate, its product and applications
1 ... 3023 3024 3025 3026 3027 3028 3029 3030 3031 3032 3033 3034 3035 3036 3037 3038 3039 3040 3041 3042 3043 ... 3163